
Seoul, South Korea Jul 21, 2025 (Issuewire.com) - Seoul, South Korea Custics, a Korean skincare brand, has launched Lesstopy ATO Cream, a gentle and functional moisturizer formulated for sensitive and eczema-prone skin. Suitable for infants, children, and adults, the cream is designed to soothe irritation and strengthen the skin barrier.
The product features patented Lycopus Lucidus Leaf Extract, a plant-based ingredient known for its calming and skin-repairing properties. It is free from artificial fragrances, artificial colors, and steroids, offering a clean formulation for those seeking safe and effective daily skincare.
"We wanted to develop a product that parents could trust as their child's first moisturizer," said a Custics representative. "Lesstopy ATO Cream reflects our commitment to gentle yet effective care, especially for those with sensitive or eczema-prone skin."
Released earlier this week in South Korea, the product will gradually expand to global markets including Singapore, Hong Kong, Taiwan, Japan, the United States, and the UAE. It will be available through Lesstopy's official website, as well as on Shopee, Amazon, Douyin, Xiaohongshu and Qoo10 Japan, ensuring broad accessibility across major e-commerce and social commerce platforms.
The brand name "Lesstopy", a combination of "Less" and "Atopy", captures Custics' mission to minimize irritation and support healthier skin through safe, science-based formulations.




Media Contact
Glovertise
More On Intelliupdate ::
- Todd Doxzon, Recognized by BestAgents.us as a 2025 Top Agent
- Passionpreneur Publishing announces the global release of Future-Proof Your Workforce
- AnneMarie Monachino: Leading the Way in Pediatric Nursing Education at Children’s Hospital of Philadelphia (CHOP)
- Amid Compliance and Transparency Trends, Bay Miner Mobile App Helps BTC and ETH Investors Grow Steadily
- Ava Dawn Williams DNP, CRNP, FNP-BC: A Trailblazer in Patient-Centered Healthcare
010-9191-6367
38, Yeongdong-daero 112-gil
Source :Custics
This article was originally published by IssueWire. Read the original article here.